ABT
Price
$131.91
Change
+$0.22 (+0.17%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
194.5B
14 days until earnings call
ZBH
Price
$112.47
Change
+$0.10 (+0.09%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
27.12B
34 days until earnings call
Ad is loading...

ABT vs ZBH

Header iconABT vs ZBH Comparison
Open Charts ABT vs ZBHBanner chart's image
Abbott Laboratories
Price$131.91
Change+$0.22 (+0.17%)
Volume$25.76K
Capitalization194.5B
Zimmer Biomet Holdings
Price$112.47
Change+$0.10 (+0.09%)
Volume$8.02K
Capitalization27.12B
ABT vs ZBH Comparison Chart
Loading...
ABT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABT vs. ZBH commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABT is a Buy and ZBH is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (ABT: $131.69 vs. ZBH: $112.37)
Brand notoriety: ABT: Notable vs. ZBH: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ABT: 61% vs. ZBH: 75%
Market capitalization -- ABT: $194.5B vs. ZBH: $27.12B
ABT [@Medical Specialties] is valued at $194.5B. ZBH’s [@Medical Specialties] market capitalization is $27.12B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABT’s FA Score shows that 3 FA rating(s) are green whileZBH’s FA Score has 1 green FA rating(s).

  • ABT’s FA Score: 3 green, 2 red.
  • ZBH’s FA Score: 1 green, 4 red.
According to our system of comparison, ABT is a better buy in the long-term than ZBH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABT’s TA Score shows that 4 TA indicator(s) are bullish while ZBH’s TA Score has 4 bullish TA indicator(s).

  • ABT’s TA Score: 4 bullish, 6 bearish.
  • ZBH’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ABT and ZBH are a bad buy in the short-term.

Price Growth

ABT (@Medical Specialties) experienced а +4.85% price change this week, while ZBH (@Medical Specialties) price change was +2.02% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.75%. For the same industry, the average monthly price growth was +3.84%, and the average quarterly price growth was +3.01%.

Reported Earning Dates

ABT is expected to report earnings on Apr 16, 2025.

ZBH is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Medical Specialties (-1.75% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABT($194B) has a higher market cap than ZBH($27.1B). ABT has higher P/E ratio than ZBH: ABT (34.38) vs ZBH (26.59). ABT YTD gains are higher at: 17.037 vs. ZBH (6.609). ABT has higher annual earnings (EBITDA): 10.5B vs. ZBH (2.22B). ABT has more cash in the bank: 7.28B vs. ZBH (416M). ZBH has less debt than ABT: ZBH (5.91B) vs ABT (15.6B). ABT has higher revenues than ZBH: ABT (40.1B) vs ZBH (7.39B).
ABTZBHABT / ZBH
Capitalization194B27.1B716%
EBITDA10.5B2.22B473%
Gain YTD17.0376.609258%
P/E Ratio34.3826.59129%
Revenue40.1B7.39B542%
Total Cash7.28B416M1,750%
Total Debt15.6B5.91B264%
FUNDAMENTALS RATINGS
ABT vs ZBH: Fundamental Ratings
ABT
ZBH
OUTLOOK RATING
1..100
6623
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
17
Undervalued
PROFIT vs RISK RATING
1..100
27100
SMR RATING
1..100
3279
PRICE GROWTH RATING
1..100
4446
P/E GROWTH RATING
1..100
9550
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABT's Valuation (11) in the Medical Specialties industry is in the same range as ZBH (17). This means that ABT’s stock grew similarly to ZBH’s over the last 12 months.

ABT's Profit vs Risk Rating (27) in the Medical Specialties industry is significantly better than the same rating for ZBH (100). This means that ABT’s stock grew significantly faster than ZBH’s over the last 12 months.

ABT's SMR Rating (32) in the Medical Specialties industry is somewhat better than the same rating for ZBH (79). This means that ABT’s stock grew somewhat faster than ZBH’s over the last 12 months.

ABT's Price Growth Rating (44) in the Medical Specialties industry is in the same range as ZBH (46). This means that ABT’s stock grew similarly to ZBH’s over the last 12 months.

ZBH's P/E Growth Rating (50) in the Medical Specialties industry is somewhat better than the same rating for ABT (95). This means that ZBH’s stock grew somewhat faster than ABT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABTZBH
RSI
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
46%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
58%
Momentum
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
63%
MACD
ODDS (%)
Bullish Trend 2 days ago
54%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
48%
Bullish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 7 days ago
60%
Bullish Trend 3 days ago
67%
Declines
ODDS (%)
Bearish Trend 13 days ago
50%
Bearish Trend 13 days ago
55%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
41%
Bearish Trend 2 days ago
60%
Aroon
ODDS (%)
Bearish Trend 2 days ago
51%
Bullish Trend 2 days ago
63%
View a ticker or compare two or three
Ad is loading...
ABT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XGN3.930.34
+9.47%
Exagen
INOD36.540.64
+1.78%
Innodata
SBT4.84N/A
N/A
Sterling Bancorp
CSGP79.18-0.05
-0.06%
CoStar Group
IGT16.07-0.19
-1.17%
International Game Technology PLC

ZBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZBH has been loosely correlated with HOLX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ZBH jumps, then HOLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZBH
1D Price
Change %
ZBH100%
-0.72%
HOLX - ZBH
47%
Loosely correlated
-0.63%
SYK - ZBH
45%
Loosely correlated
+0.28%
MDT - ZBH
44%
Loosely correlated
-1.52%
BDX - ZBH
41%
Loosely correlated
-1.32%
ABT - ZBH
38%
Loosely correlated
-0.72%
More